Literature DB >> 31395582

FLT3-ITD gets by with a little help from PRMT1.

Kira Gritsman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31395582      PMCID： PMC6688432          DOI： 10.1182/blood.2019001876

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

1.  Internal tandem duplications of the FLT3 gene are present in leukemia stem cells.

Authors:  Mark Levis; Kathleen M Murphy; Rosalyn Pham; Kyu-Tae Kim; Adam Stine; Li Li; Ian McNiece; B Douglas Smith; Donald Small
Journal:  Blood       Date:  2005-03-29       Impact factor: 22.113

2.  PRMT1 interacts with AML1-ETO to promote its transcriptional activation and progenitor cell proliferative potential.

Authors:  Wei-Jong Shia; Akiko J Okumura; Ming Yan; Ali Sarkeshik; Miao-Chia Lo; Shinobu Matsuura; Yukiko Komeno; Xinyang Zhao; Stephen D Nimer; John R Yates; Dong-Er Zhang
Journal:  Blood       Date:  2012-04-12       Impact factor: 22.113

Review 3.  The roles of FLT3 in hematopoiesis and leukemia.

Authors:  D Gary Gilliland; James D Griffin
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

4.  A panoramic view of acute myeloid leukemia.

Authors:  Sai-Juan Chen; Yang Shen; Zhu Chen
Journal:  Nat Genet       Date:  2013-06       Impact factor: 38.330

Review 5.  Structural and functional alterations of FLT3 in acute myeloid leukemia.

Authors:  Soheil Meshinchi; Frederick R Appelbaum
Journal:  Clin Cancer Res       Date:  2009-06-23       Impact factor: 12.531

6.  PRMT1-mediated FLT3 arginine methylation promotes maintenance of FLT3-ITD+ acute myeloid leukemia.

Authors:  Xin He; Yinghui Zhu; Yi-Chun Lin; Min Li; Juan Du; Haojie Dong; Jie Sun; Lei Zhu; Hanying Wang; Zonghui Ding; Lei Zhang; Lianjun Zhang; Dandan Zhao; Zhihao Wang; Herman Wu; Han Zhang; Wenjuan Jiang; Yang Xu; Jian Jin; Yudao Shen; Jeff Perry; Xinyang Zhao; Bin Zhang; Songbai Liu; Sheng-Li Xue; Binghui Shen; Chun-Wei Chen; Jianjun Chen; Samer Khaled; Ya-Huei Kuo; Guido Marcucci; Yun Luo; Ling Li
Journal:  Blood       Date:  2019-06-19       Impact factor: 25.476

Review 7.  Targeting FLT3 mutations in AML: review of current knowledge and evidence.

Authors:  Naval Daver; Richard F Schlenk; Nigel H Russell; Mark J Levis
Journal:  Leukemia       Date:  2019-01-16       Impact factor: 11.528

8.  Targeting Aberrant Epigenetic Networks Mediated by PRMT1 and KDM4C in Acute Myeloid Leukemia.

Authors:  Ngai Cheung; Tsz Kan Fung; Bernd B Zeisig; Katie Holmes; Jayant K Rane; Kerri A Mowen; Michael G Finn; Boris Lenhard; Li Chong Chan; Chi Wai Eric So
Journal:  Cancer Cell       Date:  2016-01-11       Impact factor: 31.743
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.